VANCOUVER, BRITISH COLUMBIA /  TheNewswire / December 4, 2017 – BioHep Technologies Ltd. (“the Company”) of 2820-200 Granville Street, Vancouver, British Columbia, announces that on November 30, 2017 it issued 4,800,000 common shares to 6 lenders which included 4,200,000 shares issued to clients of Pathfinder Asset Management Limited (“Pathfinder”) pursuant to the conversion of $120,000 aggregate principal amount of convertible promissory notes (the “Notes”) due December 2, 2017 (the “Conversion”).

The Notes were convertible at a rate of $0.025 per common share (“Share”) of the Company. As a result, Pathfinder increased the shares under management from 1,590,353 Shares representing 37.86% of the Company’s issued and outstanding share capital at the time of conversion to  5,790,353 Shares, representing approximately 61.28% of the Company’s issued and outstanding share capital as of today’s date.

 

For further information, please contact:

Chester Shynkaryk
Chief Executive Officer, Chief Financial Officer & Director
Phone: (604) 722-9140

     

Forward-Looking Statements

 

Except for statements of historical fact, this news release contains certain "forward‐looking information" within the meaning of applicable securities laws. Forward‐looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward‐looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward‐looking statements, including, among others, the use of proceeds for the purposes indicated. The Company undertakes no obligation to update forward‐looking information if circumstances or management's estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward‐looking statements. More detailed information about potential factors that could affect projected results is included in the documents filed from time to time with the Canadian securities regulatory authorities by the Company.